These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17669570)

  • 1. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP).
    Maeshima H; Ohnuma T; Sakai Y; Shibata N; Baba H; Ihara H; Higashi M; Ohkubo T; Nozawa E; Abe S; Ichikawa A; Nakano Y; Utsumi Y; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1410-8. PubMed ID: 17669570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP).
    Higa M; Ohnuma T; Maeshima H; Hatano T; Hanzawa R; Shibata N; Sakai Y; Suzuki T; Arai H
    Neurosci Lett; 2010 Jan; 469(1):55-9. PubMed ID: 19931593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
    Shibata H; Tani A; Chikuhara T; Kikuta R; Sakai M; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
    Psychiatry Res; 2009 May; 167(1-2):88-96. PubMed ID: 19351574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.
    Arai S; Shibata H; Sakai M; Ninomiya H; Iwata N; Ozaki N; Fukumaki Y
    Psychiatr Genet; 2009 Feb; 19(1):6-13. PubMed ID: 19125103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia.
    Ohnuma T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):29-39. PubMed ID: 20828596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the TrkB gene and schizophrenia in the Japanese population: Juntendo University Schizophrenia Projects (JUSP).
    Higashi M; Higashi S; Ohnuma T; Shibata N; Sakai Y; Arai H
    Neurosci Lett; 2007 Sep; 425(1):1-5. PubMed ID: 17720314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
    Cai HL; Zhu RH; Li HD; Zhang XH; Hu L; Yang W; Ye HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1273-8. PubMed ID: 20637820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: an association study.
    Schwab SG; Plummer C; Albus M; Borrmann-Hassenbach M; Lerer B; Trixler M; Maier W; Wildenauer DB
    Psychiatr Genet; 2008 Feb; 18(1):25-30. PubMed ID: 18197082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
    Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
    Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.
    Butticaz C; Werge T; Beckmann JS; Cuénod M; Do KQ; Rivolta C
    Psychiatr Genet; 2009 Aug; 19(4):201-8. PubMed ID: 19455074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
    Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No genetic association between the SLC1A2 gene and Japanese patients with schizophrenia.
    Nagai Y; Ohnuma T; Karibe J; Shibata N; Maeshima H; Baba H; Hatano T; Hanzawa R; Arai H
    Neurosci Lett; 2009 Oct; 463(3):223-7. PubMed ID: 19660525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of the genetic association between the U2AF homology motif (UHM) kinase 1 (UHMK1) gene and schizophrenia on chromosome 1q23.3.
    Puri V; McQuillin A; Datta S; Choudhury K; Pimm J; Thirumalai S; Krasucki R; Lawrence J; Quested D; Bass N; Crombie C; Fraser G; Walker N; Moorey H; Ray MK; Sule A; Curtis D; St Clair D; Gurling H
    Eur J Hum Genet; 2008 Oct; 16(10):1275-82. PubMed ID: 18414510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A family-based association study of the myelin-associated glycoprotein and 2',3'-cyclic nucleotide 3'-phosphodiesterase genes with schizophrenia.
    Voineskos AN; de Luca V; Bulgin NL; van Adrichem Q; Shaikh S; Lang DJ; Honer WG; Kennedy JL
    Psychiatr Genet; 2008 Jun; 18(3):143-6. PubMed ID: 18496213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.